There is no association related with low anxiety level and cardiovascular diseases in older people
DOI:
https://doi.org/10.19230/jonnpr.3773Keywords:
Anxiety, aged, cardiovascular diseases, cardiovascular risk factorsAbstract
Objective. Aging implies suffering from chronic diseases and anxiety. The objectives are to relate anxiety with cardiovascular diseases (CVD) and their risk factors (CVRF). Also with physical activity (PA) and the consumption of alcohol and tobacco.
Methods. Observational and analytical, cross-sectional study. An amount of 27 volunteers have participated (16 women) older than 65 years. Anxiety was assessed with the Hamilton scale. The rest of variables through structured survey. Descriptive statistics and bivariate analysis were used.
Results. Average age 75.3 years. Average anxiety 10.4. The alcoholic drinkers presented an anxiety of 6.7 versus 15.9 in non-alcoholic drinkers (p = 0.004). The mean somatic anxiety was 3.1 in those who did another type of PA compared to 4.3 in those who did not (p = 0.025).
Conclusions. No relationship was found between anxiety and CVD and their CVRF. Neither with tobacco consumption. There is with alcohol consumption and PA.
Downloads
References
Vidal MJ. Aspectos sociodemográficos de la población mayor. En: Fernández JN, Coordinador. Informe 2016. Las personas mayores en España. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2017. p. 35-104.
Instituto Nacional de Estadística (INE) (Notas de prensa de 10 de octubre de 2018, actualizado el 5 de noviembre de 2018).
Nota Técnica Encuesta Nacional de Salud. España 2017. 26 de junio de 2018.
Casado P. La salud en las personas mayores. En: Fernández JN, Coordinador. Informe 2016. Las personas mayores en España. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2017. p. 267-84.
Cabrera I, Montorio I. Ansiedad y envejecimiento. Rev Esp Geriatr Gerontol. 2009;44(2):106-11.
Laidlaw K, Knight, B. Handbook of Emotional Disorders in Later Life. Assessment and Treatment. Oxford: Oxford university press; 2008.
Villagrasa B, Olaya B, Lopez-Anton R, de la Cámara C, Lobo A, Santabárbara J. Prevalence of anxiety disorder among older adults in Spain: A meta-analysis. J Affect Disord. 2019;246:408-17.
Pary R, Sarai SK, Micchelli A, Lippmann S. (2019). Anxiety Disorders in Older Patients. Prim Care Companion CNS Disord. 2019;21(1):doi:10.4088/PCC.18nr02335.
De Beurs E, Beekman A, Geerlings S, Deeg D, van Dyck R, van Tilburg W. On becoming depressed in late life: Similar vulnerability factosr but different effects of stressful life events.Br J Psychiatry. 2001;179:426-31.
Mehta KM, Simonsick EM, Penninx BW, Schulz R, Rubin SM, Satterfield S. et al. Prevalence and correlates of anxiety symptoms in well-functioning older adults: findings from the health aging and body composition study. J Am Geriatr Soc. 2003;51(4):499-504.
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315-81.
Centeno AM, Rojano P. Conceptos y anamnesis del consumo de alcohol en la consulta de Atención Primaria. Medicina General. 2000;29:957-62.
Pérez-Jiménez F, Pascual V, Meco JF, Pérez Martínez P, Delgado J, Domenech M, et al. Documento de recomendaciones de la SEA 2018. El estilo de vida en la prevención cardiovascular. Clín Invest Arterioscler. 2018;30(6):280-310.
Aranceta-Bartrina J, Serra-Majem L, Foz-Sala M, Moreno-Esteban B. Grupo Colaborativo SEEDO. Prevalencia de la obesidad en España. Med Clin (Barc). 2005;125(12):460-6.
Lobo A, Chamorro L, Luque A, Dal-Ré R, Badia X, Baró E; Grupo de Validación en Español de Escalas Psicométricas (GVEEP). Validación de las versiones en español de la Montgomery-Asberg Depression Rating Scale y la Hamilton Anxiety Rating Scale para la evaluación de la depresión y de la ansiedad. Med Clin (Barc).2002;118(13):493-9.
Causapié P, Balbontín A, Porras M, Mateo A. Envejecimiento activo. Libro Blanco. Madrid: Ministerio de Sanidad, Política Social e Igualdad; 2011.
Montorio I, Losada A, Márquez M, Nuevo R. Programa psicoeducativo de tratamiento de la preocupación patológica en personas mayores: un estudio piloto. Rev Esp Geriatr Gerontol. 2000;35(1):24-9.
Rafsten L, Danielsson A, Sunnerhagen KS. Anxiety after stroke: a systematic review and meta-analysis. J Rehabil Med. 2018;50(9):769-78.
Richards SH, Anderson L, Jenkinson CE, Whalley B, Rees K, Davies P, et al. Psychological interventions for coronary heart disease. Cochrane Database Syst Rev. 2017;28(4): doi: 10.1002/14651858.CD002902.pub4.
O’Keefe-McCarthy S, Ready L. Impact of prodromal symptoms on future adverse cardiac-related events: a systematic review. J Cardiovasc Nurs. 2016;31(1):E1-10.
Turner S, Mota N, Bolton J, Sareen J. Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature. Depress Anxiety. 2018;35(9):851-60.
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
